GPs / Community Nurses

Drug monitoring guidelines

Variations in monitoring requirements may occur and this should be read in conjunction with:

• medication specific information provided by the rheumatology unit
• manufacturer's data sheet.

If you have any concerns or queries regarding your patient's blood monitoring, please contact us.

If you advise a patient to withhold medication, please let us know for our records:

Contact us

For details of standard drug monitoring for patients on long-term treatment please refer to:

BOB ICS Shared Care Guidelines 'Rheumatology Monitoring General Guidance'.

For specific advice on methotrexate use please see:

Paediatric and adolescent guidance - British Society for Rheumatology

For information on monitoring of biologics in children and adolescents please see:

Oxford Academic Rheumatology - British Society for Rheumatology